PeptideStack
5.2kquestions
20kanswers
220users

Bioburden, sterility and endotoxin are three different tests — what does each one actually prove?

Asked 30 Aug 2024Modified 19 months agoViewed 11k times
29

A COA I was sent lists "Sterility: Sterile filtered (0.22 um)" and nothing else microbiological. Another lists "Bioburden: less than 10 CFU/g — Pass". A third lists "Endotoxin: less than 10 EU/mg — Pass" and no microbiology at all.

I had been treating all three of those as roughly the same claim, on the reasoning that if a product is clean it is clean. Having read a bit I now suspect they are three unrelated tests that answer three unrelated questions, and that "sterile filtered" may not be a test result at all.

Could someone lay out precisely what each test measures, what it cannot detect, and what a lyophilised research peptide vial realistically has and has not been subjected to? I am particularly interested in whether "sterile filtered" tells me anything about the vial in my hand, given that whatever was filtered was presumably a bulk solution that then went through a lyophiliser and a filling operation.

sterility
sterility

Sterility as a test result rather than an adjective. Covers what a sterility test actually measures, why "sterile filtered" on a document is close…

122 questions
endotoxin
endotoxin

Bacterial endotoxin: LAL and kinetic chromogenic methods, how an endotoxin limit is derived from a dose, why endotoxin survives autoclaving, and…

14 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
shareeditfollowflag
OS
askedorla_sheridan14k2730 Aug 2024
8The short version: two of your three lines are results and one is a description of a process step. – micron22 3 months ago
add a comment

3 Answers

Accepted answer first, then by votes
94

Accepted answer

Three tests, three questions, no overlap. And your suspicion about "sterile filtered" is correct: it is a process description, not a test result, and it appears on a COA in the space where a result should be.

BioburdenSterilityBacterial endotoxin
Question answeredHow many viable organisms are present?Are there zero viable organisms?How much Gram-negative cell-wall lipopolysaccharide is present?
Result typeA count (CFU/g or CFU/mL)Pass or failA number (EU/mg or EU/mL)
Compendial chapterUSP 61 and 62, EP 2.6.12/2.6.13USP 71, EP 2.6.1USP 85 and 86, EP 2.6.14 and 2.6.32
Turnaround3 to 5 days14 days minimumUnder 2 hours
Destructive?YesYes, and it consumes many containersYes, but micrograms
Detects dead organisms?NoNoYes — this is the point
Detects fungi/yeast?Yes, as TYMCYes, via SCDM at 20 to 25 degreesNo
Detects Gram-positive contamination?YesYesNo — Staphylococcus produces no endotoxin
Survives autoclaving?n/an/aYes, almost entirely

Bioburden

A plate count. Dissolve or suspend a weighed sample, plate on soybean-casein digest agar for total aerobic microbial count and on Sabouraud dextrose agar for total combined yeasts and moulds, incubate, count colonies. It is a quantitative test applied to material that is not claimed to be sterile. Its normal role is as an in-process control on the solution about to be sterile-filtered, where a typical action limit is 10 CFU per 100 mL of filter feed.

A bioburden count on a finished vial is therefore an odd thing to report. It is real data, and it is the wrong test for something presented as injectable-grade: it says the vial is not heavily contaminated, and explicitly does not say the vial is sterile. A pass is compatible with several live organisms per vial.

Sterility

The absence test. Either membrane filtration (dissolve the product, filter through 0.45 um, transfer the membrane to media) or direct inoculation. Two media, two temperatures: Fluid Thioglycollate Medium at 30 to 35 degrees for aerobes and anaerobes, Soybean-Casein Digest Medium at 20 to 25 degrees for fungi and aerobes. Fourteen days. Any growth in either is a failure pending investigation.

Two things about it that people do not expect. First, it requires a method suitability demonstration: you must show that the product itself does not inhibit growth, by spiking with a panel of challenge organisms and confirming they grow within three days (bacteria) or five (fungi) in the product's presence. Skipping this is how you produce a false pass on an antimicrobial product. Second, it is statistically very weak, which is the subject of a different question in this tag, but the headline is that testing 20 vials from a lot with 0.1% contamination detects it about 2% of the time.

Endotoxin

Measures a molecule, not an organism. LPS from the Gram-negative outer membrane persists long after the cell is dead and after any sterilising process. Its two blind spots: it sees nothing from Gram-positive bacteria or fungi, and it says nothing about whether anything is alive.

Now: "sterile filtered (0.22 um)"

What passing a solution through a 0.22 um membrane achieves: removal of organisms larger than the retention rating. The validation challenge organism is Brevundimonas diminuta at 10^7 per square centimetre, which is why 0.22 um is the accepted sterilising grade.

What it does not achieve:

  • It does not remove endotoxin. LPS monomers are a few kilodaltons and pass a 0.22 um membrane as if it were not there. A solution can be sterile-filtered and grossly pyrogenic. This is the single most important thing in this answer.
  • It does not remove mycoplasma or the smallest bacteria reliably; 0.1 um is used where that matters.
  • It says nothing about what happened afterwards. The solution was filtered, then it was filled into vials, then partially stoppered, then loaded into a lyophiliser, then dried over a day or two, then stoppered and capped. Every one of those steps is an opportunity for ingress, and controlling them is the entire discipline of aseptic processing — laminar flow, environmental monitoring, gowning, media fills. A filtration step at the front of that chain guarantees nothing at the end of it.
  • It is not a test. There is no result, no acceptance criterion, no method and nothing that could have failed.

And in a significant number of cases the phrase is simply inapplicable: if the vendor bought purified peptide powder, weighed it into vials and capped them, nothing was ever filtered. The line was copied from a template.

What a research-grade lyophilised peptide vial has actually been through

Realistically, for most of this market: synthesis, prep-HPLC purification, bulk lyophilisation of the pooled fractions, then weighing of powder into vials in a room that is clean but not classified, and capping. No terminal sterilisation, no aseptic fill validation, no sterility test, often no endotoxin test. Some larger houses do better and can show the data; assume the floor unless shown otherwise.

Which means the honest reading of your three COAs is: one has an endotoxin result, one has a bioburden count, and one has a sentence. None of the three has a sterility result. That is normal for the category, and the correct response is to know it rather than to read "sterile filtered" as reassurance. These are research-use-only materials not approved for human administration, and the documentation gap is one of several reasons that framing exists.

edited 23 Sept 2024 by seven_day_half — corrected a unit error in the worked example

shareimprove this answerflag
SH
answered · acceptedseven_day_half16k183 Sept 2024
3LPS passing a 0.22 um filter unimpeded is the fact that should be on the front page of every one of these COAs. – Dr_Marek_Zielinski 4 months ago
2The template-copying point is real. I have seen "sterile filtered" on a COA for a powder the vendor openly said they never dissolved. – Dr_Ingrid_Baumgartner 3 months ago
Method suitability on the sterility test is the other silent failure. An antimicrobial product can pass by suppressing its own test. – v_ramaswamy 7 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
31

Worth adding the fourth test nobody lists, because it is the one that would actually tell you what you want to know about a lyophilised vial: container closure integrity.

A sterility test consumes the vials it tests, so it can never tell you about the vial you hold. What can, in principle, is evidence that the container system maintains its seal. The relevant methods are helium leak detection, high-voltage leak detection, vacuum decay and dye ingress, and the accepted maximum allowable leakage limit for a sterile product sits around 6 um equivalent hole size — below which microbial ingress is not observed.

Why this matters more for a lyophilised product than for a solution: the lyophiliser stoppers under partial vacuum, so a properly sealed vial holds a slight negative pressure or an inert headspace. That vacuum is a free integrity indicator you can check yourself. When you pierce a good vial with a needle you get a small suck-in; when you pierce one that lost its seal months ago you get nothing. It is crude, it is not quantitative, and a vial filled at ambient pressure never had a vacuum to lose — but on product that was genuinely lyophilised in-vial, a dead-flat headspace is a real finding.

Practical checks that cost nothing before you assume a vial is intact:

  • Cake appearance. A collapsed, melted-back or shrunken cake means the cycle ran above the collapse temperature or the vial warmed in transit. Neither is a sterility finding but both indicate poor process control.
  • Cake colour. Any yellowing or browning on a peptide that should be white.
  • Stopper seating and crimp. A stopper sitting proud, or a crimp you can rotate by hand, is a seal you cannot trust.
  • Particulates after reconstitution, viewed against a black background under a single point source. Fibres and specks are a filling-environment signal.

None of that substitutes for a test. All of it is available to you for free, and it catches the gross failures that no COA would ever have reported because the COA describes a different vial.

shareimprove this answerflag
IB
answeredilaria_bertone43k3821 Dec 2024
12

One clarification on the bioburden column of the table, because the units confuse people into over-reading a pass.

"Less than 10 CFU/g" on a 10 mg vial is a nearly vacuous statement, and the reason is the mass. Ten milligrams is 0.01 g. A limit of 10 CFU per gram translates to 0.1 CFU per vial, which is not a physically meaningful quantity — you cannot have a tenth of an organism. In practice the lab dissolved a weighed sample, plated a volume of it, and saw no colonies, and then expressed the detection limit per gram because that is the convention in USP 61.

What that actually establishes: the sample they plated contained no detectable viable organisms at the plating volume used. Given the tiny sample masses involved, the detection limit per vial is often 1 CFU at best, meaning the result cannot distinguish a clean vial from one carrying a single organism. And a single viable organism in a solution held at room temperature for a fortnight is not a rounding error; it is a growth curve.

So read a bioburden pass on a small-mass vial as "not grossly contaminated", which is worth having and is not the same as clean. The test with the statistical power to say more is the 14-day sterility test on many containers, and essentially nobody in this market runs it, because it costs more than the batch is worth and it destroys the vials it tests.

shareimprove this answerflag
MF
answeredmeniscus_film34k3810 Dec 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.